JP2009537601A - 神経因性疼痛の治療用のミルタザピン - Google Patents

神経因性疼痛の治療用のミルタザピン Download PDF

Info

Publication number
JP2009537601A
JP2009537601A JP2009511495A JP2009511495A JP2009537601A JP 2009537601 A JP2009537601 A JP 2009537601A JP 2009511495 A JP2009511495 A JP 2009511495A JP 2009511495 A JP2009511495 A JP 2009511495A JP 2009537601 A JP2009537601 A JP 2009537601A
Authority
JP
Japan
Prior art keywords
mirtazapine
treatment
pain
neuropathic pain
neuropathic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009511495A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009537601A5 (enExample
Inventor
ホートン，アンドレア
ライフト，ヘラルドウス・ステフアヌス・フランシスカス
Original Assignee
ナームローゼ・フエンノートチヤツプ・オルガノン
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ナームローゼ・フエンノートチヤツプ・オルガノン filed Critical ナームローゼ・フエンノートチヤツプ・オルガノン
Publication of JP2009537601A publication Critical patent/JP2009537601A/ja
Publication of JP2009537601A5 publication Critical patent/JP2009537601A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP2009511495A 2006-05-22 2007-05-21 神経因性疼痛の治療用のミルタザピン Pending JP2009537601A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06114316 2006-05-22
PCT/EP2007/054872 WO2007135123A2 (en) 2006-05-22 2007-05-21 Mirtazapine for the treatment of neuropathic pain

Publications (2)

Publication Number Publication Date
JP2009537601A true JP2009537601A (ja) 2009-10-29
JP2009537601A5 JP2009537601A5 (enExample) 2010-07-01

Family

ID=37006417

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009511495A Pending JP2009537601A (ja) 2006-05-22 2007-05-21 神経因性疼痛の治療用のミルタザピン

Country Status (8)

Country Link
EP (1) EP2026814A2 (enExample)
JP (1) JP2009537601A (enExample)
AR (1) AR061046A1 (enExample)
CA (1) CA2651607A1 (enExample)
MX (1) MX2008014287A (enExample)
PE (1) PE20080455A1 (enExample)
TW (1) TW200808804A (enExample)
WO (1) WO2007135123A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014240383A (ja) * 2013-05-16 2014-12-25 国立大学法人 千葉大学 癌転移抑制剤

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3261645T3 (pl) 2015-02-27 2021-12-06 Dechra Limited Pobudzanie apetytu, zarządzanie utratą masy ciała, i leczenie anoreksji u psów i kotów

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002515438A (ja) * 1998-05-19 2002-05-28 ダルフージー ユニバーシティ 局所的な無痛のための三環式抗鬱薬の使用
WO2005005410A1 (en) * 2003-07-10 2005-01-20 Akzo Nobel N.V. A method for the preparation of enantiomerically pure mirtazapine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0204050A3 (en) * 2000-01-19 2004-09-28 Akzo Nobel Nv Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone
US7074961B2 (en) * 2000-09-26 2006-07-11 The Brigham And Women's Hospital, Inc. Antidepressants and their analogues as long-acting local anesthetics and analgesics
TW200538100A (en) * 2004-04-21 2005-12-01 Akzo Nobel Nv Mirtazapine salts

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002515438A (ja) * 1998-05-19 2002-05-28 ダルフージー ユニバーシティ 局所的な無痛のための三環式抗鬱薬の使用
WO2005005410A1 (en) * 2003-07-10 2005-01-20 Akzo Nobel N.V. A method for the preparation of enantiomerically pure mirtazapine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6012052712; Ｃ．Ｍａｔｔｉａ　ｅｔ　ａｌ．: Ｍｉｎｅｒｖａ　Ａｎｅｓｔｅｓｉｏｌｏｇｉｃａ ｖｏｌ．６８，　Ｎｏ．３, 2002, ｐ．１０５-１１４ *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014240383A (ja) * 2013-05-16 2014-12-25 国立大学法人 千葉大学 癌転移抑制剤

Also Published As

Publication number Publication date
TW200808804A (en) 2008-02-16
EP2026814A2 (en) 2009-02-25
WO2007135123A3 (en) 2008-03-13
CA2651607A1 (en) 2007-11-29
WO2007135123A2 (en) 2007-11-29
MX2008014287A (es) 2008-11-18
AR061046A1 (es) 2008-07-30
PE20080455A1 (es) 2008-06-25

Similar Documents

Publication Publication Date Title
US8309535B2 (en) Compositions and methods to treat recurrent medical conditions
JP2025092508A (ja) デクスメデトミジン製剤を使用する睡眠障害の予防または治療
EP2311446A1 (en) Compositions comprising Tramadol and Celecoxib in the treatment of pain
US20200323828A1 (en) Methods of treating behavior alterations
US11285099B2 (en) Topical phenytoin for use in the treatment of peripheral neuropathic pain
KR20070083826A (ko) 우울증을 위한 부가 요법
JP2003012557A (ja) 不安及びうつ病のための多剤併用治療
JPWO2002053153A1 (ja) 神経因性疼痛治療及び予防薬
JP2005531612A (ja) ネフォパムの製剤および痛みの治療におけるその使用
Bufalari et al. Preemptive carprofen for peri-operative analgesia in dogs undergoing Tibial Plateau Leveling Osteotomy (TPLO): a prospective, randomized, blinded, placebo controlled clinical trial
EP1535615A1 (en) Composition for nasal absorption
WO2019126256A1 (en) Supramolecular hydrogel applications to the carotid bodies
EP3062791B1 (en) Novel treatments for attention and cognitive disorders, and for dementia associated with a neurodegenerative disorder
JP2009537601A (ja) 神経因性疼痛の治療用のミルタザピン
US20070270413A1 (en) Mirtazapine for the treatment of neuropathic pain
CN114080221B (zh) 用于减轻疼痛的布洛芬与曲马多的组合
RU2799049C2 (ru) Способы лечения изменений поведения
HK40122445A (en) Methods of treating behavior alterations
Divakar et al. Efficacy Of Low Dose Ketamine Infusion For Postoperative Analgesia In Upper Abdominal Surgeries
KR20220110259A (ko) 통증 질환에 사용하기 위한 미르타자핀 및 티자니딘 배합물
HK40070462B (zh) 用於疼痛疾患的米氮平和替扎尼定组合
HK40070462A (en) Mirtazapine and tizanidine combination for use in pain disorders
HK40067137A (en) Combination of ibuprofen and tramadol for relieving pain
TW200906406A (en) Use of a compound that is a neurokinin A NK2 receptor antagonist for the preparation of medicaments for use in the prevention and treatment of sexual dysfunctions
JP2011509981A (ja) 神経障害性疼痛の治療に使用される化合物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100506

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100506

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20120308

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120403

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20120423

RD07 Notification of extinguishment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7427

Effective date: 20120613

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121009

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130618